[324] K. McCullough, J. Martindale, L. Klotz, T. Aw, and N. Holbrook. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating bcl2 and perturbing the cellular redox state. Science Signalling, 21(4):1249, 2001. [325] B. McEllin, C. Camacho, B. Mukherjee, B. Hahm, N. Tomimatsu, R. Bachoo, and S. Burma. Pten loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly (adp-ribose) polymerase inhibitors. Cancer research, 70(13):5457–5464, 2010. [326] R. McLendon, A. Friedman, D. Bigner, and E. Van Meir. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 2008. [327] M. Mehling, P. Simon, M. Mittelbronn, R. Meyermann, S. Ferrone, M. Weller, and H. Wiendl. WHO grade associated downregulation <strong>of</strong> MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? Acta neuropathologica, 114(2):111–9, 2007. [328] K. Meletis, F. Barnabé-Heider, M. Carlén, E. Evergren, N. Tomilin, O. Shupliakov, and J. Frisén. Spinal cord injury reveals multilineage differentiation <strong>of</strong> ependymal cells. PLoS biology, 6(7):e182, 2008. [329] I. Mellingh<strong>of</strong>f, M. Wang, I. Vivanco, D. Haas-Kogan, S. Zhu, E. Dia, K. Lu, K. Yoshimoto, J. Huang, D. Chute, et al. Molecular determinants <strong>of</strong> the response <strong>of</strong> glioblastomas to egfr kinase inhibitors. New England Journal <strong>of</strong> Medicine, 353(19):2012–2024, 2005. [330] X. Meng, M. Leyva, M. Jenny, I. Gross, S. Benosman, B. Fricker, S. Harlepp, P. Hébraud, A. Boos, P. Wlosik, et al. A ruthenium-containing organometallic compound reduces tumor growth through induction <strong>of</strong> the endoplasmic reticulum stress gene chop. Cancer research, 69(13):5458–5466, 2009. [331] T. Mercer, M. Dinger, and J. Mattick. Long non-coding rnas: insights into functions. Nature Reviews Genetics, 10(3):155–159, 2009. [332] F. Merkle, A. Tramontin, J. García-Verdugo, and A. Alvarez-Buylla. Radial glia give rise to adult neural stem cells in the subventricular zone. Proceedings <strong>of</strong> the National Academy <strong>of</strong> Sciences <strong>of</strong> the United States <strong>of</strong> America, 101(50):17528, 2004. [333] MGI. Mouse genome informatics database. http://www.informatics.jax.org/. [334] P. S. Mischel, S. F. Nelson, and T. F. Cloughesy. Molecular analysis <strong>of</strong> glioblastoma: pathway pr<strong>of</strong>iling and its implications for patient therapy. Cancer biology and therapy, 2(3):242–7, 2003. [335] S. Mitsui, N. Yamaguchi, Y. Osako, and K. Yuri. Enzymatic properties and localization <strong>of</strong> motopsin (prss12), a protease whose absence causes mental retardation. Brain research, 1136:1–12, 2007. [336] K. Mochizuki, N. Fine, T. Fujisawa, and M. Gorovsky. Analysis <strong>of</strong> a piwi-related gene implicates small rnas in genome rearrangement in tetrahymena. Cell, 110(6):689–699, 2002. [337] E. Mohorko, R. Glockshuber, and M. Aebi. Oligosaccharyltransferase: the central enzyme <strong>of</strong> n-linked protein glycosylation. Journal <strong>of</strong> inherited metabolic disease, pages 1–10, 2011. [338] K. Mokhtari, S. Paris, L. Aguirre-Cruz, N. Privat, E. Criniere, Y. Marie, J. Hauw, M. Kujas, D. Rowitch, K. Hoang-Xuan, et al. Olig2 expression, gfap, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathology and applied neurobiology, 31(1):62–69, 2005. [339] M. Montanez-Wiscovich, D. Seachrist, M. Landis, J. Visvader, B. Andersen, and R. Keri. Lmo4 is an essential mediator <strong>of</strong> erbb2/her2/neu-induced breast cancer cell cycle progression. Oncogene, 28(41):3608–3618, 2009. [340] M. E. Montanez-Wiscovich, D. D. Seachrist, M. D. Landis, J. Visvader, B. Andersen, and R. A. Keri. Lmo4 is an essential mediator <strong>of</strong> erbb2/her2/neu-induced breast cancer cell cycle progression. Oncogene, 28:3608–3618, 2009. [341] A. Moolwaney and O. Igwe. Regulation <strong>of</strong> the cyclooxygenase-2 system by interleukin- 1β through mitogen-activated protein kinase signaling pathways: A comparative study <strong>of</strong> human neuroglioma and neuroblastoma cells. Molecular brain research, 137(1):202– 212, 2005.
[342] H. Moon, M. Ahn, J. Park, K. Min, Y. Kwon, and K. Kim. Negative regulation <strong>of</strong> hypoxia inducible factor-1α by necdin. FEBS letters, 579(17):3797–3801, 2005. [343] T. Mori, A. Buffo, and M. Götz. The novel roles <strong>of</strong> glial cells revisited: the contribution <strong>of</strong> radial glia and astrocytes to neurogenesis. Current topics in developmental biology, 69:67–99, 2005. [344] M. Morimoto-Tomita, K. Uchimura, A. Bistrup, D. Lum, M. Egeblad, N. Boudreau, Z. Werb, and S. Rosen. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia (New York, NY), 7(11):1001, 2005. [345] S. Morrison and J. Kimble. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441(7097):1068–1074, 2006. [346] A. S. Morrissy, R. D. Morin, A. Delaney, T. Zeng, H. Mcdonald, S. Jones, Y. Zhao, M. Hirst, and M. A. Marra. Next-generation tag sequencing for cancer gene expression pr<strong>of</strong>iling. Genome Research, 19(10):1825–1835, Oct. 2009. [347] C. M. Morshead and D. van der Kooy. Disguising adult neural stem cells. Current opinion in neurobiology, 14(1):125–131, Feb. 2004. [348] G. Mosieniak, B. Pyrzynska, and B. Kaminska. Nuclear factor <strong>of</strong> activated t cells (nfat) as a new component <strong>of</strong> the signal transduction pathway in glioma cells. Journal <strong>of</strong> neurochemistry, 71(1):134–141, 1998. [349] W. Mueller, C. Nutt, M. Ehrich, M. Riemenschneider, A. Von Deimling, D. Van Den Boom, and D. Louis. Downregulation <strong>of</strong> runx3 and tes by hypermethylation in glioblastoma. Oncogene, 26(4):583–593, 2006. [350] J. Mukai, T. Hachiya, S. Shoji-Hoshino, M. Kimura, D. Nadano, P. Suvanto, T. Hanaoka, Y. Li, S. Irie, L. Greene, et al. Nade, a p75ntr-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75ntr. Journal <strong>of</strong> Biological Chemistry, 275(23):17566, 2000. [351] J. Mukai, P. Suvant, and T. Sato. Nerve growth factor-dependent regulation <strong>of</strong> nadeinduced apoptosis. Vitamins & Hormones, 66:385–402, 2003. [352] I. Muñoz-Sanjuán and A. H. Brivanlou. <strong>Neural</strong> induction, the default model and embryonic stem cells. Nature Reviews Neuroscience, 3(4):271–280, apr 2002. [353] A. Murat, E. Migliavacca, T. Gorlia, W. Lambiv, T. Shay, M. Hamou, N. De Tribolet, L. Regli, W. Wick, M. Kouwenhoven, et al. <strong>Stem</strong> cell-related self-renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. Journal <strong>of</strong> Clinical Oncology, 26(18):3015–3024, 2008. [354] N. Nakagomi, T. Nakagomi, S. Kubo, A. Nakano-Doi, O. Saino, M. Takata, H. Yoshikawa, D. Stern, T. Matsuyama, and A. Taguchi. Endothelial cells support survival, proliferation, and neuronal differentiation <strong>of</strong> transplanted adult ischemiainduced neural stem/progenitor cells after cerebral infarction. <strong>Stem</strong> <strong>Cells</strong>, 27(9):2185– 2195, 2009. [355] C. Napoli, C. Lemieux, and R. Jorgensen. Introduction <strong>of</strong> a chimeric chalcone synthase gene into petunia results in reversible co-suppression <strong>of</strong> homologous genes in trans. The Plant Cell Online, 2(4):279, 1990. [356] K. Nave. Axon-glial signaling and the glial support <strong>of</strong> axon function. Annual review <strong>of</strong> neuroscience, 2008. [357] R. Nawroth, A. Van Zante, S. Cervantes, M. McManus, M. Hebrok, and S. Rosen. Extracellular sulfatases, elements <strong>of</strong> the wnt signaling pathway, positively regulate growth and tumorigenicity <strong>of</strong> human pancreatic cancer cells. PLoS One, 2(4):e392, 2007. [358] S. Ng, K. Buckingham, C. Lee, A. Bigham, H. Tabor, K. Dent, C. Huff, P. Shannon, E. Jabs, D. Nickerson, et al. Exome sequencing identifies the cause <strong>of</strong> a mendelian disorder. Nature Genetics, 42(1):30–35, 2009. [359] C. B. Nielsen, N. Shomron, R. Sandberg, E. Hornstein, J. Kitzman, and C. B. Burge. Determinants <strong>of</strong> targeting by endogenous and exogenous microRNAs and siRNAs. RNA, 13(11):1894–910, 2007.
- Page 1 and 2:
Transcriptional Characterization of
- Page 3 and 4:
This dissertation is my own work an
- Page 5 and 6:
Acknowledgements I would like to th
- Page 7 and 8:
5.9 External Dataset Expression Cor
- Page 9 and 10:
Introduction 1
- Page 11 and 12:
1.1 Glial Cells in the Central Nerv
- Page 13 and 14:
1.2 Glioblastoma Multiforme Introdu
- Page 15 and 16:
1.2 Glioblastoma Multiforme Introdu
- Page 17 and 18:
1.2 Glioblastoma Multiforme Introdu
- Page 19 and 20:
1.3 Primary and Secondary Glioblast
- Page 21 and 22:
1.3 Primary and Secondary Glioblast
- Page 23 and 24:
1.3 Primary and Secondary Glioblast
- Page 25 and 26:
1.3 Primary and Secondary Glioblast
- Page 27 and 28:
1.3 Primary and Secondary Glioblast
- Page 29 and 30:
1.4 Pathways Involved in Glioblasto
- Page 31 and 32:
1.4 Pathways Involved in Glioblasto
- Page 33 and 34:
1.4 Pathways Involved in Glioblasto
- Page 35 and 36:
1.4 Pathways Involved in Glioblasto
- Page 37 and 38:
1.4 Pathways Involved in Glioblasto
- Page 39 and 40:
1.5 Pathway Crosstalk Introduction
- Page 41 and 42:
Chapter 2 Neurogenesis Contents 2.1
- Page 43 and 44:
2.1 Radial Glia Introduction VZ adj
- Page 45 and 46:
2.2 Neural Stem Cells Introduction
- Page 47 and 48:
2.2 Neural Stem Cells Introduction
- Page 49 and 50:
2.2 Neural Stem Cells Introduction
- Page 51 and 52:
2.2 Neural Stem Cells Introduction
- Page 53 and 54:
2.2 Neural Stem Cells Introduction
- Page 55 and 56:
2.2 Neural Stem Cells Introduction
- Page 57 and 58:
2.2 Neural Stem Cells Introduction
- Page 59 and 60:
2.2 Neural Stem Cells Introduction
- Page 61 and 62:
2.2 Neural Stem Cells Introduction
- Page 63 and 64:
2.2 Neural Stem Cells Introduction
- Page 65 and 66:
Chapter 3 Brain Cancer Stem Cells C
- Page 67 and 68:
3.1 The Cancer Stem Cell Hypothesis
- Page 69 and 70:
3.1 The Cancer Stem Cell Hypothesis
- Page 71 and 72:
3.2 Brain Cancer Stem Cells Introdu
- Page 73 and 74:
3.2 Brain Cancer Stem Cells Introdu
- Page 75 and 76:
3.2 Brain Cancer Stem Cells Introdu
- Page 77 and 78:
3.2 Brain Cancer Stem Cells Introdu
- Page 79 and 80:
3.2 Brain Cancer Stem Cells Introdu
- Page 81 and 82:
3.3 Glioma Culture Systems Introduc
- Page 83 and 84:
3.3 Glioma Culture Systems Introduc
- Page 85 and 86:
3.3 Glioma Culture Systems Introduc
- Page 87 and 88:
3.3 Glioma Culture Systems Introduc
- Page 89 and 90:
3.3 Glioma Culture Systems Introduc
- Page 91 and 92:
3.3 Glioma Culture Systems Introduc
- Page 93 and 94:
Chapter 4 The Non-Coding RNA World
- Page 95 and 96:
4.1 MicroRNA regulation Introductio
- Page 97 and 98:
4.1 MicroRNA regulation Introductio
- Page 99 and 100:
4.2 Target Prediction and Validatio
- Page 101 and 102:
Methods 93
- Page 103 and 104:
5.1 Tag-sequencing Data Processing
- Page 105 and 106:
5.1 Tag-sequencing Data Processing
- Page 107 and 108:
5.2 Array Comparative Genomic Hybri
- Page 109 and 110:
5.4 Quantitative Real Time-PCR Vali
- Page 111 and 112:
5.4 Quantitative Real Time-PCR Vali
- Page 113 and 114:
5.4 Quantitative Real Time-PCR Vali
- Page 115 and 116:
5.5 Literature Mining Methods Figur
- Page 117 and 118:
5.5 Literature Mining Methods How m
- Page 119 and 120:
5.6 Differential Isoform Expression
- Page 121 and 122:
5.9 External Dataset Expression Cor
- Page 123 and 124:
5.10 Glioblastoma Pathway Construct
- Page 125 and 126:
5.11 MicroRNA Target Prediction Ana
- Page 127 and 128:
Results 119
- Page 129 and 130:
6.2 Tag mapping Results Table 6.1:
- Page 131 and 132:
6.2 Tag mapping Results 123 Figure
- Page 133 and 134:
6.3 Copy Number Aberrations Results
- Page 135 and 136:
6.3 Copy Number Aberrations Results
- Page 137 and 138:
6.4 Core Differentially Expressed G
- Page 139 and 140:
6.4 Core Differentially Expressed G
- Page 141 and 142:
6.4 Core Differentially Expressed G
- Page 143 and 144:
6.4 Core Differentially Expressed G
- Page 145 and 146:
6.5 Large-scale qRT-PCR Validation
- Page 147 and 148:
6.5 Large-scale qRT-PCR Validation
- Page 149 and 150:
6.5 Large-scale qRT-PCR Validation
- Page 151 and 152:
6.6 Literature Mining for Different
- Page 153 and 154:
6.7 Isoform Differential Expression
- Page 155 and 156:
6.7 Isoform Differential Expression
- Page 157 and 158:
6.7 Isoform Differential Expression
- Page 159 and 160:
6.7 Isoform Differential Expression
- Page 161 and 162:
6.7 Isoform Differential Expression
- Page 163 and 164:
6.7 Isoform Differential Expression
- Page 165 and 166:
6.8 Long ncRNA Differential Express
- Page 167 and 168:
6.8 Long ncRNA Differential Express
- Page 169 and 170:
Chapter 7 Dataset Correlation Analy
- Page 171 and 172:
7.1 Enrichment Analysis Results Tab
- Page 173 and 174:
7.1 Enrichment Analysis Results Fig
- Page 175 and 176:
7.1 Enrichment Analysis Results Tab
- Page 177 and 178:
7.2 Glioblastoma Expression Signatu
- Page 179 and 180:
7.3 Tumour Expression Correlation R
- Page 181 and 182:
7.3 Tumour Expression Correlation R
- Page 183 and 184:
7.3 Tumour Expression Correlation R
- Page 185 and 186:
7.3 Tumour Expression Correlation R
- Page 187 and 188:
7.3 Tumour Expression Correlation R
- Page 189 and 190:
7.3 Tumour Expression Correlation R
- Page 191 and 192:
7.4 Survival Analysis Results Table
- Page 193 and 194:
7.4 Survival Analysis Results 867 g
- Page 195 and 196:
7.5 Glioblastoma Pathway Analysis R
- Page 197 and 198:
7.5 Glioblastoma Pathway Analysis R
- Page 199 and 200:
7.5 Glioblastoma Pathway Analysis R
- Page 201 and 202:
7.5 Glioblastoma Pathway Analysis R
- Page 203 and 204:
7.5 Glioblastoma Pathway Analysis R
- Page 205 and 206:
7.5 Glioblastoma Pathway Analysis R
- Page 207 and 208:
7.5 Glioblastoma Pathway Analysis R
- Page 209 and 210:
7.5 Glioblastoma Pathway Analysis R
- Page 211 and 212:
8.1 Principles Results say, this is
- Page 213 and 214:
8.3 Databases Results Figure 8.1: O
- Page 215 and 216:
8.3 Databases Results Figure 8.3: W
- Page 217 and 218:
8.4 Filters Results Bayesian method
- Page 219 and 220:
8.5 Target Prediction Ensemble Anal
- Page 221 and 222:
8.5 Target Prediction Ensemble Anal
- Page 223 and 224:
8.5 Target Prediction Ensemble Anal
- Page 225 and 226:
8.5 Target Prediction Ensemble Anal
- Page 227 and 228:
8.5 Target Prediction Ensemble Anal
- Page 229 and 230:
9.1. Digital Profiling of GNS Cell
- Page 231 and 232:
9.1. Digital Profiling of GNS Cell
- Page 233 and 234:
9.1. Digital Profiling of GNS Cell
- Page 235 and 236:
9.1. Digital Profiling of GNS Cell
- Page 237 and 238:
9.1. Digital Profiling of GNS Cell
- Page 239 and 240:
9.2. MicroRNA Target Prediction Ana
- Page 241 and 242:
9.3. Concluding Remarks Appendix pr
- Page 243 and 244:
A.1 Differential Expression Appendi
- Page 245 and 246:
A.1 Differential Expression Appendi
- Page 247 and 248:
A.1 Differential Expression Appendi
- Page 249 and 250:
A.1 Differential Expression Appendi
- Page 251 and 252:
A.1 Differential Expression Appendi
- Page 253 and 254:
A.1 Differential Expression Appendi
- Page 255 and 256:
A.1 Differential Expression Appendi
- Page 257 and 258:
A.1 Differential Expression Appendi
- Page 259 and 260:
A.2 Classified Differential Express
- Page 261 and 262:
A.2 Classified Differential Express
- Page 263 and 264:
A.2 Classified Differential Express
- Page 265 and 266:
A.3 Quantitative RT-PCR Appendix Ta
- Page 267 and 268:
A.3 Quantitative RT-PCR Appendix We
- Page 269 and 270:
A.3 Quantitative RT-PCR Appendix Ta
- Page 271 and 272:
A.3 Quantitative RT-PCR Appendix We
- Page 273 and 274:
A.4 Tag-seq vs qRT-PCR Correlation
- Page 275 and 276:
Appendix "BEX5", "DIAPH2", "GBP3",
- Page 277 and 278:
End Select End If End Sub Appendix
- Page 279 and 280:
If NameStr.ToLower().Equals("query"
- Page 281 and 282:
Appendix C Long ncRNAs We detected
- Page 283 and 284:
C. Long ncRNAs Appendix Tag Accessi
- Page 285 and 286:
D.1 Pathway Interactions Appendix F
- Page 287 and 288:
D.1 Pathway Interactions Appendix F
- Page 289 and 290: D.1 Pathway Interactions Appendix F
- Page 291 and 292: D.2 Pathway Images Appendix Figure
- Page 293 and 294: D.2 Pathway Images Appendix Figure
- Page 295 and 296: E. Exon Array Data Appendix Average
- Page 297 and 298: E. Exon Array Data Appendix Average
- Page 299 and 300: E. Exon Array Data Appendix Average
- Page 301 and 302: E. Exon Array Data Appendix Average
- Page 303 and 304: E. Exon Array Data Appendix Average
- Page 305 and 306: E. Exon Array Data Appendix Average
- Page 307 and 308: E. Exon Array Data Appendix Average
- Page 309 and 310: F. MicroRNA Array Data Appendix Tab
- Page 311 and 312: F. MicroRNA Array Data Appendix GNS
- Page 313 and 314: F. MicroRNA Array Data Appendix GNS
- Page 315 and 316: Ln Natural logarithm LOH Loss of He
- Page 317 and 318: 3.3 Schematisation of cell cycle ph
- Page 319 and 320: 8.3 Workflows at the core of the pr
- Page 321 and 322: 7.1 Selected Gene Ontology terms an
- Page 323 and 324: Bibliography [1] Cell signaling tec
- Page 325 and 326: [38] G. Bain, D. Kitchens, M. Yao,
- Page 327 and 328: [78] S. Bustin, V. Benes, J. Garson
- Page 329 and 330: [112] M. Czystowska, J. Han, M. Szc
- Page 331 and 332: [153] T. Fujiwara, M. Bandi, M. Nit
- Page 333 and 334: [192] M. Hernandez, M. Nieto, and M
- Page 335 and 336: [231] T.-M. Kim, W. Huang, R. Park,
- Page 337 and 338: [268] H. Lemjabbar-Alaoui, A. van Z
- Page 339: [305] K. MAEDA, S. MATSUHASHI, K. T
- Page 343 and 344: [379] D. Park and J. Rich. Biology
- Page 345 and 346: [417] P. Rakic. Guidance of neurons
- Page 347 and 348: [456] T. Shima, N. Okumura, T. Taka
- Page 349 and 350: [490] P. A. C. t’Hoen, Y. Ariyure
- Page 351 and 352: [523] T. Watanabe, A. Takeda, T. Ts